Between 2025 and 2030, the market will add USD 5.3 million, accounting for 46.5% of total decade-long growth. This phase is ...
Europe remains a robust market, projected to increase from USD 5.8 million in 2025 to USD 8.2 million by 2035 (CAGR 3.5%).
Directed evolution strategies have previously been used to evolve DNA polymerases with enhanced activity 6, greater thermostability 7, ability to use ribonucleotide analogs 8,9 and to incorporate 2′-O ...
https://doi.org/10.5325/jpennacadscie.93.2.0118 • https://www.jstor.org/stable/10.5325/jpennacadscie.93.2.0118 Copy URL The synthetic method recently established by ...